飛魚科技(01022.HK)對人壽保險保單進行退保 金額1440萬美元
格隆匯8月28日丨飛魚科技(01022.HK)公佈,於2020年8月28日,董事會已批准並遞交相關表格予宏利,以就公司作為投保人及受益人按退保金額(經宏利扣除任何保單欠款及退保費用後,在結算時以現金收取)對人壽保險保單進行退保。
退保金額指人壽保險保單的現金金額,其按各保單保費加上累計已賺取利息再扣減保險成本而釐定。於本公告日期,人壽保險保單的退保金額合共為1440萬美元。
董事認為,退保事項為集團提供良機,可為其一般營運資金及╱或其他投資機遇產生現金流入。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.